SandboxAB: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 40: | Line 40: | ||
|} | |} | ||
<BR> | |||
*In patients with suspected cystitis, urine culture and susceptibility tests should be performed, with starting of empirical therapy. | *In patients with suspected cystitis, urine culture and susceptibility tests should be performed, with starting of empirical therapy. | ||
Line 49: | Line 50: | ||
*[[Nitrofurantoin]], [[fosfomycin]] and mecillinam shouldn't be used when pyelonephritis is suspected, because they have weak penetration to the renal tissue. | *[[Nitrofurantoin]], [[fosfomycin]] and mecillinam shouldn't be used when pyelonephritis is suspected, because they have weak penetration to the renal tissue. | ||
*Use of broad-spectrum antimicrobials resulted multi- | *Use of broad-spectrum antimicrobials resulted multi-drug resistant organisms, so they are used as alternative to the first line drugs in case of allergy, availability, or tolerance. |
Revision as of 06:19, 17 January 2014
‡Avoid if resistance prevalence is known to exceed 20% or if used for UTI in previous 3 months. ♦Pivmecillinam is available in some European countries, not licensed in US.
|